Cargando…
A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, but its regulatory mechanism remains unclear and potential clinical biomarkers are still lacking. Co-regulation of TFs and miRNAs in HCC and FFL module studies may help to identify more precise and critical...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265408/ https://www.ncbi.nlm.nih.gov/pubmed/35805200 http://dx.doi.org/10.3390/cells11132116 |
_version_ | 1784743206600048640 |
---|---|
author | Hu, Hui Huang, Wei Zhang, Hong Li, Jianye Zhang, Qiong Miao, Ya-Ru Hu, Fei-Fei Gan, Lu Su, Zhenhong Yang, Xiangliang Guo, An-Yuan |
author_facet | Hu, Hui Huang, Wei Zhang, Hong Li, Jianye Zhang, Qiong Miao, Ya-Ru Hu, Fei-Fei Gan, Lu Su, Zhenhong Yang, Xiangliang Guo, An-Yuan |
author_sort | Hu, Hui |
collection | PubMed |
description | Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, but its regulatory mechanism remains unclear and potential clinical biomarkers are still lacking. Co-regulation of TFs and miRNAs in HCC and FFL module studies may help to identify more precise and critical driver modules in HCC development. Here, we performed a comprehensive gene expression and regulation analysis for HCC in vitro and in vivo. Transcription factor and miRNA co-regulatory networks for differentially expressed genes between tumors and adjacent tissues revealed the critical feed-forward loop (FFL) regulatory module miR-9-5p/FOXO1/CPEB3 in HCC. Gain- and loss-of-function studies demonstrated that miR-9-5p promotes HCC tumor proliferation, while FOXO1 and CPEB3 inhibit hepatocarcinoma growth. Furthermore, by luciferase reporter assay and ChIP-Seq data, CPEB3 was for the first time identified as a direct downstream target of FOXO1, negatively regulated by miR-9-5p. The miR-9-5p/FOXO1/CPEB3 FFL was associated with poor prognosis, and promoted cell growth and tumor progression of HCC in vitro and in vivo. Our study identified for the first time the existence of miR-9-5p/FOXO1/CPEB3 FFL and revealed its regulatory role in HCC progression, which may represent a new potential target for cancer therapy. |
format | Online Article Text |
id | pubmed-9265408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92654082022-07-09 A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma Hu, Hui Huang, Wei Zhang, Hong Li, Jianye Zhang, Qiong Miao, Ya-Ru Hu, Fei-Fei Gan, Lu Su, Zhenhong Yang, Xiangliang Guo, An-Yuan Cells Article Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, but its regulatory mechanism remains unclear and potential clinical biomarkers are still lacking. Co-regulation of TFs and miRNAs in HCC and FFL module studies may help to identify more precise and critical driver modules in HCC development. Here, we performed a comprehensive gene expression and regulation analysis for HCC in vitro and in vivo. Transcription factor and miRNA co-regulatory networks for differentially expressed genes between tumors and adjacent tissues revealed the critical feed-forward loop (FFL) regulatory module miR-9-5p/FOXO1/CPEB3 in HCC. Gain- and loss-of-function studies demonstrated that miR-9-5p promotes HCC tumor proliferation, while FOXO1 and CPEB3 inhibit hepatocarcinoma growth. Furthermore, by luciferase reporter assay and ChIP-Seq data, CPEB3 was for the first time identified as a direct downstream target of FOXO1, negatively regulated by miR-9-5p. The miR-9-5p/FOXO1/CPEB3 FFL was associated with poor prognosis, and promoted cell growth and tumor progression of HCC in vitro and in vivo. Our study identified for the first time the existence of miR-9-5p/FOXO1/CPEB3 FFL and revealed its regulatory role in HCC progression, which may represent a new potential target for cancer therapy. MDPI 2022-07-05 /pmc/articles/PMC9265408/ /pubmed/35805200 http://dx.doi.org/10.3390/cells11132116 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hu, Hui Huang, Wei Zhang, Hong Li, Jianye Zhang, Qiong Miao, Ya-Ru Hu, Fei-Fei Gan, Lu Su, Zhenhong Yang, Xiangliang Guo, An-Yuan A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma |
title | A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma |
title_full | A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma |
title_fullStr | A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma |
title_full_unstemmed | A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma |
title_short | A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma |
title_sort | mir-9-5p/foxo1/cpeb3 feed-forward loop drives the progression of hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265408/ https://www.ncbi.nlm.nih.gov/pubmed/35805200 http://dx.doi.org/10.3390/cells11132116 |
work_keys_str_mv | AT huhui amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT huangwei amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT zhanghong amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT lijianye amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT zhangqiong amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT miaoyaru amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT hufeifei amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT ganlu amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT suzhenhong amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT yangxiangliang amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT guoanyuan amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT huhui mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT huangwei mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT zhanghong mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT lijianye mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT zhangqiong mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT miaoyaru mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT hufeifei mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT ganlu mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT suzhenhong mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT yangxiangliang mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma AT guoanyuan mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma |